IP Library Assignment 059692/0342
Patent Assignment
Reel/Frame 059692/0342

Assignment of Assignor's Interest

Recorded: 2022-04-25 Pages: 3
Assignor
LEGEAI-MALLET, LAURENCE
Executed: 2014-06-04
Assignee
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, RUE DE TOLBIAC, PARIS, 75013, FRANCE
Covered Property (1)
Antagonist of the Fibroblast Growth Factor Receptor 3 (FGFR3) for Use in the Treatment or the Prevention of Skeletal Disorders Linked with Abnormal Activation of FGFR3
Patent: 9,931,341 →
Application: 14/844,041 →
Publication: US 2016/0051549
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Jul 22, 2021
From: UNIVERSITE DE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7
To: UNIVERSITE DE PARIS
Reel/Frame 056947/0567 →
Change of Name Mar 25, 2022
From: UNIVERSITÉ DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 059504/0225 →
Assignment of Assignor's Interest Apr 25, 2022
From: MUNNICH, ARNOLD; BUSCA, PATRICIA; BARBAULT, FLORENT
To: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); UNIVERSITE PARIS DESCARTES; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS
Reel/Frame 059692/0913 →